Jean‐Pierre Jeannon

Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie et al. · The Journal of Immunology · 2013 · 128 citations

Cell Therapy, Therapeutic Opportunity, Adaptive Immune System +21

Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer

May CI van Schalkwyk, Sophie Papa, Jean‐Pierre Jeannon et al. · Human Gene Therapy Clinical Development · 2013 · 123 citations

Sentinel Lymph Node Biopsy for T1/T2 Oral Cavity Squamous Cell Carcinoma—A Prospective Case Series

Thomas F. Pézier, Iain J. Nixon, Ben Gurney et al. · Annals of Surgical Oncology · 2012 · 63 citations

Medicine, Oral Cavity, Surgical Pathology +6

Prognostic indicators in carcinoma of the nasal vestibule

Jean‐Pierre Jeannon, Philip J. Riddle, Jonathan C. Irish et al. · Clinical Otolaryngology · 2007 · 57 citations

Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit experience

Francesca De Felice, C. Thomas, Vinod Patel et al. · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · 2016 · 54 citations

Neck Cancer, Radiation Therapy, Medicine +10